Porsbjerg, Celeste M.; Menzies-Gow, Andrew N.; Tran, Trung N.; Murray, Ruth B.; Unni, Bindhu; Audrey Ang, Shi Ling; Alacqua, Marianna; Al-Ahmad, Mona; Al-Lehebi, Riyad; Altraja, Alan; Belevskiy, Andrey S.; Björnsdóttir, Unnur S.; Bourdin, Arnaud; Busby, John; Canonica, G. Walter; Christoff, George C.; Cosio, Borja G.; Costello, Richard W.; FitzGerald, J. Mark; Fonseca, João A.; Hansen, Susanne; Heaney, Liam G.; Heffler, Enrico; Hew, Mark; Iwanaga, Takashi; Jackson, Daniel J.; Kocks, Janwillem W.H.; Kallieri, Maria; Bruce Ko, Hsin Kuo; Koh, Mariko Siyue; Larenas-Linnemann, Désirée; Lehtimäki, Lauri A.; Loukides, Stelios; Lugogo, Njira; Maspero, Jorge; Papaioannou, Andriana I.; Perez-de-Llano, Luis; Pitrez, Paulo Márcio; Popov, Todor A.; Rasmussen, Linda M.; Rhee, Chin Kook; Sadatsafavi, Mohsen; Schmid, Johannes; Siddiqui, Salman; Taillé, Camille; Taube, Christian; Torres-Duque, Carlos A.; Ulrik, Charlotte; Upham, John W.; Wang, Eileen; Wechsler, Michael E.; Bulathsinhala, Lakmini; Carter, Victoria; Chaudhry, Isha; Eleangovan, Neva; Hosseini, Naeimeh; Rowlands, Mari Anne; Price, David B.; van Boven, Job F.M. (2022)
review
Background: Regulatory bodies have approved five biologics for severe asthma. However, regional differences in accessibility may limit the global potential for personalized medicine. Objective: To compare global differences ...
